Dr. Marta Costa is a Principal Scientist at the Instituto de Biologia Experimental e Tecnológica (iBET) and holds a PhD in Bioengineering (MIT Portugal Program, pursued at Instituto Superior Técnico and Georgia Institute of Technology, 2012 – 2017). Over the last 14 years, Dr. Costa has focused on the development of novel bioprocesses to manufacture cell-based products both in academic (Instituto Superior Técnico, Georgia Institute of Technology) and in industrial settings (Cell and Gene Therapy Catapult, London, UK).

Dr. Marta Costa is working to overcome the challenges of generating extracellular vesicles (EVs) from mesenchymal stromal cells (MSCs), and recently her focus has been on scaling up MSC-EV manufacturing as well as on developing potent immunotherapies through enhanced bioprocess control.